ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
10 Studies on InnoCare’s Oncology Pipelines Selected at the Upcoming 65th Annual Meeting of ASH
November 15, 2023InnoCare Pharma,announced today that 10 studies from InnoCare's oncology pipeline were selected for presentation at the 65th American Society of Hematology (ASH) Annual Meeting on December 9-12, 2023 in San Diego, California, United States. -
InnoCare Pharma announced 2023 interim results as of 30 June 2023
September 04, 2023InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced 2023 interim results as of 30 June 2023. -
InnoCare Announces Approval of Clinical Trial of pan-TRK Inhibitor Zurletrectinib for the Treatment of Pediatric Patients in China
July 27, 2023InnoCare announces approval of clinical trial of pan-TRK inhibitor Zurletrectinib for the treatment of pediatric patients in China.
Pharma Sources Insight January 2025
